The parent molecule, PT3, was raised against Alzheimer’s disease brain purified paired helical filament, and preclinical studies with the humanized version, JNJ-63733657, have demonstrated reductions in tau seeding. This evidence concerns the gene ZNF135 and early-onset autosomal dominant Alzheimer disease.